GREENLAND MINES LTD Repayments of Related Party Debt
GREENLAND MINES LTD (GRML) reported Repayments of Related Party Debt of $200.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2024-04-17
- GREENLAND MINES LTD repayments of related party debt for the quarter ending 2022-12-31 was $0.00.
- GREENLAND MINES LTD repayments of related party debt for the quarter ending 2022-09-30 was $0.00.
- GREENLAND MINES LTD repayments of related party debt for fiscal 2022 was $200.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 6 month as first filed | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 9 month as first filed | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $0.00 derived: sum of 2 quarters · filed 2024-04-17 | $200.00K 10-K · filed 2024-04-17 | $8.51K 10-K · filed 2023-04-10 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $200.00K 10-Q · filed 2023-11-17 | $8.51K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-21 | $8.51K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |